Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Aprepitant
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Aprepitant 80mg capsules
0406000ADAAAAAA
|
Aprepitant | Aprepitant | Central Nervous System | 50 |
|
Aprepitant 125mg capsules and Aprepitant 80mg capsules
0406000ADAAACAC
|
Aprepitant | Aprepitant | Central Nervous System | 12 |
|
Aprepitant 125mg capsules
0406000ADAAABAB
|
Aprepitant | Aprepitant | Central Nervous System | 3 |
|
Aprepitant 25mg/5ml oral suspension
0406000ADAAAEAE
|
Aprepitant | Aprepitant | Central Nervous System | 2 |
|
Aprepitant 125mg oral powder sachets
0406000ADAAAGAG
|
Aprepitant | Aprepitant | Central Nervous System | 1 |
|
Aprepitant 30mg/5ml oral suspension
0406000ADAAAFAF
|
Aprepitant | Aprepitant | Central Nervous System | No data available |
|
Aprepitant 40mg/5ml oral suspension
0406000ADAAADAD
|
Aprepitant | Aprepitant | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.